Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05150197 · ClinicalTrials.gov registry record · NA
Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease
A NA study of Visual Field Defect, Peripheral, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT05150197: Recruiting NA study of Visual Field Defect, Peripheral, sponsored by Duke University.
NCT05150197 is a NA study of Visual Field Defect, Peripheral that is actively recruiting participants, run by Duke University. The registered enrollment target is 1,000 participants, above the 32-participant average among 6 other Visual Field Defect, Peripheral trials with a reported enrollment target (3025% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05150197, a NA study of Visual Field Defect, Peripheral, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test a new way of measuring the peripheral vision (called a visual field test) using a device which can be worn as goggles rather than being a large instrument the patient must sit at. This new visual field test (called VisuALL) is an FDA-approved virtual reality system which has been used in adults and children. This study will compare the performance of the VisuALL to the standard testing for peripheral vision, which is called the Humphrey Visual Field (HVF) test. The study will recruit both healthy children, as well children and young adults who have eye conditions which require visual field testing as part of their standard care. The test will be performed on a day when the child or young adult already has a scheduled eye appointment as standard care. The test does not touch the eyes or require any eye drops to be given, and there is no known risk associated with the test itself. There may be a risk of loss of confidentiality. Participating in this study will require approximately 30 minutes, has no extra cost associated with it, and will be compensated by a parking pass for the day of the visit. There are no direct benefits for participants. Selected participants will be also be given training and then loaned a home VisuALL system to allow home visual field testing. If your child is selected, additional information would be provided.
Primary Outcome
Mean deviation of the visual field is one score measured in decibels calculated from device reading
Conditions Studied
Interventions
- DEVICE VisuALL
- DEVICE Humphrey Visual Field
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-01-19 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
What NCT05150197 shows while recruiting
NCT05150197 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 32-participant average among 6 other Visual Field Defect, Peripheral trials with a reported enrollment target (3025% higher).
The record links to 1 condition, with Visual Field Defect, Peripheral appearing as the primary indexed condition, and to 2 interventions - of which VisuALL is the first listed.
NCT05150197 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05150197 about?
NCT05150197 is a clinical study titled "Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease". The purpose of this study is to test a new way of measuring the peripheral vision (called a visual field test) using a device which can be worn as goggles rather than being a large instrument the patient must sit at. This new visual field test (called VisuALL) is an FDA-approved virtual reality syst...
What is the current status of trial NCT05150197?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-01-19. Estimated completion is 2026-02-01.
What conditions does trial NCT05150197 study?
This clinical trial studies the following conditions: Visual Field Defect, Peripheral.
What interventions are being tested in trial NCT05150197?
The interventions under investigation include: VisuALL (DEVICE), Humphrey Visual Field (DEVICE).
Who is sponsoring clinical trial NCT05150197?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05150197 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Field Defect, Peripheral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vision Loss Impact on Navigation in Virtual Reality
RECRUITING · NA
-
Visual Plasticity Following Brain Lesions
RECRUITING · NA
-
Improving Visual Field Deficits With Noninvasive Brain Stimulation
RECRUITING · NA
-
Feasibility Tests for Various Prism Configurations for Visual Field Loss
RECRUITING · NA
-
Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking
ACTIVE NOT RECRUITING · NA
-
Visual Rehabilitation After Occipital Stroke
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI